NG
BHVN icon

Novem Group’s Biohaven BHVN Stock Holding History

Novem Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Hold
52,000
– – 0.08% 224
2026
Q1 		$440K Buy
+52,000
New +$569K 0.05% 289

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Novem Group's BHVN Position: Q2 2026 in Review

Novem Group held its Biohaven (BHVN) position steady in Q2 2026 at 52,000 shares worth $774K. The position accounts for 0.08% of the portfolio, ranked #224.

Novem Group first reported a position in BHVN in Q1 2026 and has held it in 2 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Novem Group held 52,000 shares of Biohaven worth $774K as of Q2 2026.
  • Novem Group left its Biohaven share count unchanged in Q2 2026.
  • Biohaven made up 0.08% of Novem Group's portfolio in Q2 2026, its #224 holding.
  • Novem Group first reported a position in Biohaven in Q1 2026 and has held it in 2 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.